AMS Q4 2024 earnings highlight 59% revenue growth, international expansion, and patient-centric strategy. Learn about future opportunities and challenges.
Several companies are reported to have delayed their upcoming initial public offerings or are considering doing so as President Trump’s ...
Sangamo Therapeutics, Inc.'s $18M Eli Lilly deal boosts CNS genomic medicines. Fabry gene therapy data in 2025 is key for ...
The recent furor around "White Lotus" and "Sex Education" star Aimee Lou Wood’s natural smile suggests we are more obsessed ...
This week we recommend a new exhibition in the home of Sigmund Freud, an action comedy about a man who feels no pain and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results